ArticleProteins2026
Alternative Conformation Prediction Using Deep Learning With Multi-MSA Strategy and Structural Clustering in CASP16.
Article in Proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Cross-protective human antibodies against the Mpox virus discovered through structure-guided screening.Cell discovery · 2026Article
- Schistosoma japonicum histone acetyltransferase 1 (SjHAT1): A novel anti-schistosomal drug target.PLoS pathogens · 2026Article
- HFB301001, an OX40-based immunotherapy, drives Treg clearance and CTL activation through optimized OX40 receptor clustering.Journal for immunotherapy of cancer · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
We report the results from the "MIEnsembles-Server" and "Zheng" groups for structure ensemble predictions in CASP16, both of which employed the EnsembleFold pipeline. Initially, multiple sequence alignments (MSAs) were generated using DeepMSA2 for proteins and rMSA for RNA targets. These MSAs were processed by newly developed deep learning methods-D-I-TASSER2 for protein monomer structure prediction, DMFold2 for protein complex structure prediction, ExFold for RNA structure prediction, and DeepProtNA for protein-nucleic acid complex structure prediction-to yield diverse structural decoys. The generated decoys were clustered into representative models corresponding to distinct conformational states using the structural clustering tool MolClust. Protein monomer targets underwent additional refinement via replica-exchange Monte Carlo (REMC) simulations with D-I-TASSER2, and these refined decoys were re-clustered with MolClust to finalize the ensemble predictions. For the 19 ensemble targets in CASP16, the final EnsembleFold models achieved an average TM-score of 0.657, representing improvements of 10.2% compared to the baseline AlphaFold3 program. Notably, EnsembleFold achieved particularly good performance for hybrid protein/nucleic-acid targets, leading to its efficacy in ensemble prediction tasks. Analysis of the resulting structural ensembles highlighted three significant insights: (i) Models derived from distinct DeepMSA2-generated MSAs typically represent different conformational states for ensemble targets; (ii) REMC simulations significantly enhance model diversity, facilitating the identification of alternative conformations; (iii) The structural clustering approach effectively identifies and selects accurate representative models for each conformational state. We further discuss potential improvements in Quality Assessment (QA) scoring methods that could further enhance the reliability and accuracy of ensemble predictions in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.